Skip to main content
Equibles

Redmile Group, LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1425738 Larkspur, CA
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,216,131
+$3,688,663 QoQ
Shares Held
3,031,009
-3.9% QoQ
Ownership
0.863%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#13
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. NUVB ranks #18 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SRRK
Scholar Rock Holding Corp
 4,311,092 $237,110,060
2 KRYS
Krystal Biotech, Inc.
 632,005 $234,897,298
3 STOK
Stoke Therapeutics, Inc.
 3,945,920 $129,110,502
4 IMNM
Immunome Inc.
 4,911,590 $104,076,592
5 NRIX
Nurix Therapeutics, Inc.
 4,073,787 $98,830,072
6 ABSI
Absci Corp
 6,739,675 $78,112,833
7 ANNX
Annexon, Inc.
 11,869,877 $67,776,997
8 RGNX
REGENXBIO Inc.
 4,368,804 $52,338,271

All Filings in NUVB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,216,131 3,031,009
2026-03-31 $13,527,468 3,153,256
2025-12-31 $28,342,773 3,163,256
2025-09-30 $11,214,733 3,031,009
2025-06-30 $5,910,467 3,031,009
2025-03-31 $5,334,575 3,031,009
2024-12-31 $8,062,483 3,031,009
2024-09-30 $6,941,010 3,031,009
2024-06-30 $8,850,546 3,031,009
2024-03-31 $11,032,872 3,031,009
2023-12-31 $4,576,823 3,031,009
2023-09-30 $4,061,552 3,031,009
2023-06-30 $5,455,816 3,031,009
2023-03-31 $5,031,474 3,031,009
2022-12-31 $5,819,537 3,031,009
2022-09-30 $6,789,460 3,031,009
2022-06-30 $11,248,337 3,471,709
2022-03-31 $18,261,189 3,471,709
2021-12-31 $31,203,576 3,671,009
2021-09-30 $45,137,629 4,541,009
2021-06-30 $42,276,793 4,541,009
2021-03-31 $47,453,544 4,541,009